| |
Axys
is pioneering a new method of drug discovery, based on sweeping
advances in the life sciences and information technologies taking place
in the past decade. Driven by the discoveries of the Human Genome
Project, breakthroughs in genetics, computer-based drug design,
combinatorial chemistry, biochemistry, and even robotics, Axys
scientists have fashioned a "drug discovery platform" to streamline the
arduous process of pharmaceutical development. The Axys strategy is to apply this comprehensive
gene-to-drug approach to drug discovery on a wide basis. Axys
scientists have used their expertise to uncover genes associated with
asthma and melanoma. Axys has recently patented a gene associated with
the "tubby" mutation in mice that could provide a potential model for
obesity in humans.
Axys is proud to share its
science and the story of drug discovery. We believe that in sharing the
knowledge, everyone can share in the promise of better health.
To
make this story of science and technology as informative as possible,
we have described the whole process from gene identification to
clinical trials in language for the non-scientist. Those who want more
technical details can use the "Technology Platform" pull-down menu on
each page or click on underlined terms in the text. For a look at the
"big picture" of what goes into creating a drug candidate, refer to the
Integrated Platform, or begin the story with Redefining Drug Discovery. |
 |
